Predicting and Preventing Immune Checkpoint Inhibitor Toxicity: Targeting Cytokines

被引：78

作者：

Kang, Jee Hye ^{[1
,2
]}

Bluestone, Jeffrey A. ^{[1
,2
,3
]}

Young, Arabella ^{[1
,2
,4
]}

机构：

[1] Univ Calif San Francisco, Sean N Parker Autoimmune Res Lab, San Francisco, CA 94143 USA

[2] Univ Calif San Francisco, Ctr Diabet, San Francisco, CA 94143 USA

[3] Sonoma Biotherapeut, San Francisco, CA USA

[4] QIMR Berghofer Med Res Inst, Herston, Qld, Australia

来源：

TRENDS IN IMMUNOLOGY | 2021年 / 42卷 / 04期

基金：

英国医学研究理事会; 美国国家卫生研究院;

关键词：

ADVERSE EVENTS; 1ST-LINE TREATMENT; ADVANCED MELANOMA; CLINICAL IMPACT; INDUCED COLITIS; TH17; CELLS; ANTI-TNF; CANCER; IPILIMUMAB; NIVOLUMAB;

D O I：

10.1016/j.it.2021.02.006

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

Cancer immunotherapies can successfully activate immune responses towards certain tumors. However, this can also result in the development of treatmentinduced immune-related adverse events (irAEs) in multiple tissues. Growing evidence suggests that cytokine production in response to these therapeutics potentiates the development of irAEs and may have predictive value as biomarkers for irAE occurrence. In addition, therapeutic agents that inhibit cytokine activity can limit the severity of irAEs, and their use is being tested in the clinical setting. This review provides an in-depth analysis of strategies to uncouple the cytokine response, that precipitates irAEs following cancer immunotherapies, from the benefit gained in promoting antitumor immunity.

引用

页码：293 / 311

页数：19

共 121 条

[1] Early introduction of selective immunosuppressive therapy associated with favorable clinical outcomes in patients with immune checkpoint inhibitor-induced colitis [J].

Abu-Sbeih, Hamzah ;

Ali, Faisal S. ;

Wang, Xuemei ;

Mallepally, Niharika ;

Chen, Ellie ;

Altan, Mehmet ;

Bresalier, Robert S. ;

Charabaty, Aline ;

Dadu, Ramona ;

Jazaeri, Amir ;

Lashner, Bret ;

Wang, Yinghong .

JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019, 7

[2] Phase II Trial of IL-12 Plasmid Transfection and PD-1 Blockade in Immunologically Quiescent Melanoma [J].

Algazi, Alain P. ;

Twitty, Christopher G. ;

Tsai, Katy K. ;

Le, Mai ;

Pierce, Robert ;

Browning, Erica ;

Hermiz, Reneta ;

Canton, David A. ;

Bannavong, Donna ;

Oglesby, Arielle ;

Francisco, Murray ;

Fong, Lawrence ;

Pittet, Mikael J. ;

Arlauckas, Sean P. ;

Garris, Christopher ;

Levine, Lauren P. ;

Bifulco, Carlos ;

Ballesteros-Merino, Carmen ;

Bhatia, Shailender ;

Gargosky, Sharron ;

Andtbacka, Robert H. I. ;

Fox, Bernard A. ;

Rosenblum, Michael D. ;

Daud, Adil I. .

CLINICAL CANCER RESEARCH, 2020, 26 (12) :2827-2837

[3] Infliximab for IPILIMUMAB-Related Colitis-Letter [J].

Arriola, Edurne ;

Wheater, Matthew ;

Karydis, Ioannis ;

Thomas, Gareth ;

Ottensmeier, Christian .

CLINICAL CANCER RESEARCH, 2015, 21 (24) :5642-5643

[4] Concurrent therapy with immune checkpoint inhibitors and TNFα blockade in patients with gastrointestinal immune-related adverse events [J].

Badran, Yousef R. ;

Cohen, Justine, V ;

Brastianos, Priscilla K. ;

Parikh, Aparna R. ;

Hong, Theodore S. ;

Dougan, Michael .

JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019, 7 (01)

[5] Enterocolitis in patients with cancer after antibody blockade of cytotoxic T-lymphocyte-associated antigen 4 [J].

Beck, Kimberly E. ;

Blansfield, Joseph A. ;

Tran, Khoi Q. ;

Feldman, Andrew L. ;

Hughes, Marybeth S. ;

Royal, Richard E. ;

Kammula, Udai S. ;

Topalian, Suzanne L. ;

Sherry, Richard M. ;

Kleiner, David ;

Quezado, Martha ;

Lowy, Israel ;

Yellin, Michael ;

Rosenberg, Steven A. ;

Yang, James C. .

JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (15) :2283-2289

[6] Association of Checkpoint Inhibitor-Induced Toxic Effects With Shared Cancer and Tissue Antigens in Non-Small Cell Lung Cancer [J].

Berner, Fiamma ;

Bomze, David ;

Diem, Stefan ;

Ali, Omar Hasan ;

Faessler, Mirjam ;

Ring, Sandra ;

Niederer, Rebekka ;

Ackermann, Christoph J. ;

Baumgaertner, Petra ;

Pikor, Natalia ;

Cruz, Cristina Gil ;

van de Veen, Willem ;

Akdis, Muebeccel ;

Nikolaev, Sergey ;

Laeubli, Heinz ;

Zippelius, Alfred ;

Hartmann, Fabienne ;

Cheng, Hung-Wei ;

Hoenger, Gideon ;

Recher, Mike ;

Goldman, Jonathan ;

Cozzi, Antonio ;

Fruek, Martin ;

Neefjes, Jacques ;

Driessen, Christoph ;

Ludewig, Burkhard ;

Hegazy, Ahmed N. ;

Jochum, Wolfram ;

Speiser, Daniel E. ;

Flatz, Lukas .

JAMA ONCOLOGY, 2019, 5 (07) :1043-1047

[7] TNFα blockade overcomes resistance to anti-PD-1 in experimental melanoma [J].

Bertrand, Florie ;

Montfort, Anne ;

Marcheteau, Elie ;

Imbert, Caroline ;

Gilhodes, Julia ;

Filleron, Thomas ;

Rochaix, Philippe ;

Andrieu-Abadie, Nathalie ;

Levade, Thierry ;

Meyer, Nicolas ;

Colacios, Celine ;

Segui, Bruno .

NATURE COMMUNICATIONS, 2017, 8

[8] Tocilizumab among patients with COVID-19 in the intensive care unit: a multicentre observational study [J].

Biran, Noa ;

Ip, Andrew ;

Ahn, Jaeil ;

Go, Ronaldo C. ;

Wang, Shuqi ;

Mathura, Shivam ;

Sinclaire, Brittany A. ;

Bednarz, Urszula ;

Marafelias, Michael ;

Hansen, Eric ;

Siegel, David S. ;

Goy, Andre H. ;

Pecora, Andrew L. ;

Sawczuk, Ihor S. ;

Koniaris, Lauren S. ;

Simwenyi, Micky ;

Varga, Daniel W. ;

Tank, Lisa K. ;

Stein, Aaron A. ;

Allusson, Valerie ;

Lin, George S. ;

Oser, William F. ;

Tuma, Roman A. ;

Reichman, Joseph ;

Brusco, Louis, Jr. ;

Carpenter, Kim L. ;

Costanzo, Eric J. ;

Vivona, Vincent ;

Goldberg, Stuart L. .

LANCET RHEUMATOLOGY, 2020, 2 (10) :E603-E612

[9] Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: American Society of Clinical Oncology Clinical Practice Guideline [J].

Brahmer, Julie R. ;

Lacchetti, Christina ;

Schneider, Bryan J. ;

Atkins, Michael B. ;

Brassil, Kelly J. ;

Caterino, Jeffrey M. ;

Chau, Ian ;

Ernstoff, Marc S. ;

Gardner, Jennifer M. ;

Ginex, Pamela ;

Hallmeyer, Sigrun ;

Chakrabarty, Jennifer Holter ;

Leighl, Natasha B. ;

Mammen, Jennifer S. ;

McDermott, David F. ;

Naing, Aung ;

Nastoupil, Loretta J. ;

Phillips, Tanyanika ;

Porter, Laura D. ;

Puzanov, Igor ;

Reichner, Cristina A. ;

Santomasso, Bianca D. ;

Seigel, Carole ;

Spira, Alexander ;

Suarez-Almazor, Maria E. ;

Wang, Yinghong ;

Weber, Jeffrey S. ;

Wolchok, Jedd D. ;

Thompson, John A. .

JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (17) :1714-+

[10] Corticosteroids, But Not TNF Antagonists, Are Associated With Adverse COVID-19 Outcomes in Patients With Inflammatory Bowel Diseases: Results From an International Registry [J].

Brenner, Erica J. ;

Ungaro, Ryan C. ;

Gearry, Richard B. ;

Kaplan, Gilaad G. ;

Kissous-Hunt, Michele ;

Lewis, James D. ;

Ng, Siew C. ;

Rahier, Jean-Francois ;

Reinisch, Walter ;

Ruemmele, Frank M. ;

Steinwurz, Flavio ;

Underwood, Fox E. ;

Zhang, Xian ;

Colombel, Jean-Frederic ;

Kappelman, Michael D. .

GASTROENTEROLOGY, 2020, 159 (02) :481-+

← 1 2 3 4 5 6 7 8 9 10 →